(Q44602602)

4 December 2017

title

Possible antioxidant and neuroprotective mechanisms of FK506 in attenuating haloperidol-induced orofacial dyskinesia (English)

1 reference

4 December 2017

1 reference

Amanpreet Singh

1

1 reference

4 December 2017

Pattipati S Naidu

series ordinal

2

1 reference

4 December 2017

Shrinivas K Kulkarni

series ordinal

3

1 reference

4 December 2017

language of work or name

English

0 references

publication date

1 September 2003

1 reference

European Journal of Pharmacology

4 December 2017

published in

1 reference

4 December 2017

volume

477

1 reference

4 December 2017

issue

2

1 reference

4 December 2017

page(s)

87-94

1 reference

Free radical mechanisms in schizophrenia and tardive dyskinesia

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902124-1

Effect of tacrolimus (FK506) in dystrophic epidermolysis bullosa: rationale and preliminary results.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902124-1

Oxidative stress, glutamate, and neurodegenerative disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902124-1

Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902124-1

Immunosuppressant FK506 enhances phosphorylation of nitric oxide synthase and protects against glutamate neurotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902124-1

Excitotoxins, aging, and environmental neurotoxins: implications for understanding human neurodegenerative diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902124-1

7 January 2021

Tissue sulfhydryl groups

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902124-1

Augmentation of rat liver regeneration by FK 506 compared with cyclosporin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902124-1

The immunosuppressant FK506 increases the rate of axonal regeneration in rat sciatic nerve

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902124-1

A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902124-1

Lower incidence of tardive dyskinesia with risperidone compared with haloperidol in older patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902124-1

Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide dismutase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902124-1

Tardive dyskinesia: An update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902124-1

Regulation of NMDA channel function by endogenous Ca(2+)-dependent phosphatase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902124-1

Suppression of nitric oxide formation by tyrosine kinase inhibitors in murine N9 microglia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902124-1

Effect of cyclosporin A on inflammatory cytokine production by human alveolar macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902124-1

Immunosuppressant FK506 promotes neurite outgrowth in cultures of PC12 cells and sensory ganglia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902124-1

Neuronal regeneration enhances the expression of the immunophilin FKBP-12

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902124-1

Potential role of calcineurin for brain ischemia and traumatic injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902124-1

Possible involvement of prostaglandins in haloperidol-induced orofacial dyskinesia in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902124-1

Effect of 5-HT1A and 5-HT2A/2C receptor modulation on neuroleptic-induced vacuous chewing movements

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902124-1

Carvedilol attenuates neuroleptic-induced orofacial dyskinesia: possible antioxidant mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902124-1

Evidence for cell loss in corpus striatum after long-term treatment with a neuroleptic drug (flupenthixol) in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902124-1

Tardive dystonia. Prevalence, risk factors, and comparison with tardive dyskinesia in a population of 200 acute psychiatric inpatients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902124-1

Glutathione depletion and formation of glutathione-protein mixed disulfide following exposure of brain mitochondria to oxidative stress.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902124-1

The preventative role of antioxidants (selegiline and vitamin E) in a rat model of tardive dyskinesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902124-1

The effect of a new immunosuppressive agent, FK-506, on xenogeneic neural transplantation in rodents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902124-1

Tacrolimus, a specific inhibitor of calcineurin, modifies the locomotor activity of quinpirole, but not that of SKF82958, in male rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902124-1

Immunophilins mediate the neuroprotective effects of FK506 in focal cerebral ischaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902124-1

Tacrolimus (FK506) ameliorates skilled motor deficits produced by middle cerebral artery occlusion in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902124-1

Calcineurin functions in Ca(2+)-activated cell death in mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902124-1

Cyclosporin A, FK-506, and rapamycin: pharmacologic probes of lymphocyte signal transduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902124-1

High brain densities of the immunophilin FKBP colocalized with calcineurin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902124-1

Neurotrophic immunophilin ligands stimulate structural and functional recovery in neurodegenerative animal models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902124-1

GPI1046 prevents dopaminergic dysfunction by activating glutathione system in the mouse striatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902124-1

Neuroprotective FK506 does not alter in vivo nitric oxide production during ischemia and early reperfusion in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902124-1

The effects of FK506, a specific calcineurin inhibitor, on methamphetamine-induced behavioral change and its sensitization in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902124-1

Mitochondrial diseases in man and mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902124-1

Ca2+-induced apoptosis through calcineurin dephosphorylation of BAD

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902124-1

Mechanisms of lipid peroxide formation in animal tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902124-1

Stimulation of hair growth by topical application of FK506, a potent immunosuppressive agent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2902124-1

10.1016/S0014-2999(03)02124-1

7 January 2021

Identifiers

DOI

1 reference

4 December 2017

1 reference